What Researchers Did
Researchers retrospectively analyzed the effects of hyperbaric oxygenation (HBO) therapy on bone marrow oedema (BME) and aseptic osteonecrosis (AON) in pediatric patients with acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL).
What They Found
Out of 291 pediatric ALL or NHL patients, 27 (9.3%) were diagnosed with BME and/or AON, with 19 of these receiving an average of 45 HBO treatments. These 27 patients, with a mean age of 8.2 years, presented with 138 lesions, of which 133 were located in the lower extremities. Girls under 10 years predominantly showed BME (33 cases), while those over 10 years predominantly had AON (28 cases).
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a potential additional treatment option for Canadian children and adolescents with acute lymphoblastic leukemia or non-Hodgkin lymphoma who develop bone marrow oedema or aseptic osteonecrosis. This could help manage painful bone complications and potentially improve quality of life for these young patients.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Germany.
Study Limitations
As a retrospective analysis, this study is limited by potential selection bias, lack of a control group, and incomplete data, which may affect the generalizability of its findings.